ABSTRACT
Both severe aortic stenosis and coronary heart disease are important cardiovascular diseases that significantly impact the quality of life and longevity of older individuals.These diseases share several risk and pathogenic factors, including age, and are often co-morbid.However, there is currently a lack of strong evidence to guide specialist management in cases where these two diseases coexist.Numerous clinical studies are underway to determine the optimal management strategy for such cases.In this article, we aim to summarize the issues related to the management of severe aortic stenosis in combination with coronary artery disease and provide theoretical guidance for clinical management.
ABSTRACT
Objective To investigate the prevalence rate of heart valve calcification and its relativity with pathological changes and clinical pathogenic factors in elder patients at autopsy Methods Pathology data at autopsy of 1047 patients with age from 60 to 106 years in Beijing Hospital from November 1954 to March 2016 were collected.Cases of heart valve calcification verified at autopsy were retrospectively reviewed.The prevalence of heart valve calcification and its relativity with age,clinical disease and coronary atherosclerosis was investigated.Results Among 1047 autopsies,aortic valve calcification(AVC)was found in 15.2 % (n=159),mitral valve calcification(MVC)in 9.6 % (n=101),both AVC and MVC calcification in 5.4 % (n =57)and heart valve calcification in 19.4 % (n =203).The prevalence of heart valve calcification was 6.4% (15/234)at age of 60-69,12.8%(37/289)at age of 70-79,22.5%(70/311)at age of 80-89 and 38.0% (81/213) at age of 90-106 years,respectively(tendency x2 =82.523,P<0.01).Calcification prevalence was significantly increased when complicated with coronary artery stenosis,hypertension,coronary artery disease (CAD),diabetes and chronic kidney disease (CKD).Multivariate regression analysis showed that age and CAD were independently risk factors for heart valve calcification(OR=1.066,95% CI:1.048-1.086,P< 0.01;OR =2.238,95% CI:1.396-3.589,P<0.01,respectively),while hypertension,diabetes and CKD were not independent risk factors(OR =1.223,95% CI:0.859-1.741,P> 0.05;OR =1.053,95% CI:0.700-1.586,P >0.05;OR =0.924,95% CI:0.610-1.399,P> 0.05,respectively).As compared with patients without heart valves calcification,patients with heart valve calcification had more increased risk for coronary atherosclerosis(OR =2.983,95a%CI:1.868-4.765,P<0.01).Conclusions Prevalence of heart valve calcification is increased in elder patients with increasing age.Prevalence of heart valve calcification is higher in CAD patients than in non-CAD patients.And heart valve calcification is sigmficantly associated with coronary atherosclerosis.
ABSTRACT
Objective: To investigate the effect of diabetes on the intensity of sarcoplasmic reticulum Ca2+-ATPase (SERCA2a)-SUMOylation and SERCA2a activity of myocardium in experimental rats. Methods: The 8 weeks old SD rats were divided into 2 groups, Diabetic group, with diet-induced type 2 diabetic rats and Control group, with normal rats. The systolic and diastolic cardiac functions were evaluated by echocardiography and left ventricular pressure measurement. The intensity of SERCA2a-SUMOylation was examined by co-immunoprecipitation and SUMOylation kit. Results: Compared with Control group, Diabetic group had decreased systolic and diastolic cardiac functions, especially for diastolic function;decreased SERCA2a protein expression and intensity of SUMOylation;decreased SUMOylation E2 (Ubc9 ) protein expression. The protein levels of SUMO1, SAE1 and SAE2 were similar between 2 groups. Conclusion: The intensity of SERCA2a-SUMOylation and Ubc9 decreased in diabetic myocardium which implies that SERCA2a-SUMOylation and Ubc9 were closely related to the damage of diabetic myocardium in experimental rats.